$QURT
Quarta-Rad, Inc.

2024 Q2 Form 10-K Financial Statement

#000149315224012312 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $29.04K $145.6K $508.3K
YoY Change -71.55% -53.51% -53.81%
Cost Of Revenue $18.42K $93.41K $325.0K
YoY Change -63.16% -34.73% -53.83%
Gross Profit $10.62K $52.16K $183.4K
YoY Change -79.81% -69.32% -53.77%
Gross Profit Margin 36.57% 35.83% 36.07%
Selling, General & Admin $84.56K $7.670K $196.1K
YoY Change 20.8% -90.07% -24.34%
% of Gross Profit 796.23% 14.7% 106.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $200.00 $800.00 $800.00
YoY Change 0.0% 300.0% 0.0%
% of Gross Profit 1.88% 1.53% 0.44%
Operating Expenses $84.56K $7.670K $196.1K
YoY Change 17.49% -90.07% -24.33%
Operating Profit -$73.94K $44.49K -$12.76K
YoY Change 281.54% -52.06% -109.28%
Interest Expense -$110.00 $24.16K $22.51K
YoY Change -98.9% -25.94% -118.92%
% of Operating Profit 54.3%
Other Income/Expense, Net $11.70K $18.83K $46.58K
YoY Change 17.0%
Pretax Income -$62.34K $87.48K $56.32K
YoY Change 271.67% -30.25% 205.21%
Income Tax $18.37K $11.83K
% Of Pretax Income 21.0% 21.0%
Net Earnings -$62.34K $69.11K $44.49K
YoY Change 370.45% -30.25% 205.19%
Net Earnings / Revenue -214.65% 47.48% 8.75%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 15.66M shares 15.67M shares 15.67M shares
Diluted Shares Outstanding 15.67M shares 15.67M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $102.6K $124.8K $124.8K
YoY Change -44.84% -73.33% -73.33%
Cash & Equivalents $63.73K $72.63K
Short-Term Investments $38.82K $52.15K $52.15K
Other Short-Term Assets
YoY Change
Inventory $8.397K $30.40K $30.40K
Prepaid Expenses
Receivables $5.573K $7.290K $7.290K
Other Receivables $25.93K $80.81K $80.81K
Total Short-Term Assets $142.5K $243.3K $243.3K
YoY Change -53.6% -66.0% -66.0%
LONG-TERM ASSETS
Property, Plant & Equipment $1.170K $1.570K $1.570K
YoY Change -40.61% -33.76% -33.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.98K $24.07K $24.07K
YoY Change 16.6% -32.95% -32.95%
Total Long-Term Assets $477.4K $440.0K $440.0K
YoY Change 7.38% 1049.95% 1050.13%
TOTAL ASSETS
Total Short-Term Assets $142.5K $243.3K $243.3K
Total Long-Term Assets $477.4K $440.0K $440.0K
Total Assets $619.9K $683.3K $683.3K
YoY Change -17.53% -9.35% -9.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $116.6K $105.2K $105.2K
YoY Change 6.0% 26.34% 26.34%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $380.3K $289.7K $289.7K
YoY Change -0.5% -28.4% -28.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $380.3K $289.7K $289.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $380.3K $289.7K $289.7K
YoY Change 0.08% -28.4% -28.4%
SHAREHOLDERS EQUITY
Retained Earnings -$108.7K $45.30K
YoY Change -614.46% 5513.26%
Common Stock $348.3K $348.3K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $239.6K $393.6K $393.6K
YoY Change
Total Liabilities & Shareholders Equity $619.9K $683.3K $683.3K
YoY Change -17.53% -9.35% -9.35%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$62.34K $69.11K $44.49K
YoY Change 370.45% -30.25% 205.19%
Depreciation, Depletion And Amortization $200.00 $800.00 $800.00
YoY Change 0.0% 300.0% 0.0%
Cash From Operating Activities -$11.85K -$70.23K $49.77K
YoY Change -218.5% -1312.95% -75.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $25.52K -$1.030K -$271.0K
YoY Change -163.8% -102.48% 62.93%
Cash From Investing Activities $25.52K -$1.030K -$271.0K
YoY Change -163.8% -102.48% 62.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -11.85K -70.23K 49.77K
Cash From Investing Activities 25.52K -1.030K -271.0K
Cash From Financing Activities
Net Change In Cash 13.67K -71.26K -221.3K
YoY Change -145.57% -250.62% -756.99%
FREE CASH FLOW
Cash From Operating Activities -$11.85K -$70.23K $49.77K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001549631
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
usd
CY2022 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
usd
CY2023 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
CY2022 QURT Payments For Proceeds From Issuance Of Notes Payable Related Party
PaymentsForProceedsFromIssuanceOfNotesPayableRelatedParty
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
usd
CY2022Q4 QURT Deferred Tax Assets Accrued Interest Related Party
DeferredTaxAssetsAccruedInterestRelatedParty
usd
CY2022Q4 QURT Deferred Tax Assets Accrued Expenses Related Party
DeferredTaxAssetsAccruedExpensesRelatedParty
usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
pure
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55964
CY2023 dei Entity Registrant Name
EntityRegistrantName
Quarta-Rad, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4232089
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1201 N. Orange St.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19801
CY2023 dei City Area Code
CityAreaCode
(310)
CY2023 dei Local Phone Number
LocalPhoneNumber
308-7887
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023 dei Trading Symbol
TradingSymbol
QURT
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Public Float
EntityPublicFloat
3958717 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15659483 shares
CY2023 dei Auditor Name
AuditorName
dbbmckennon
CY2023 dei Auditor Firm
AuditorFirmId
3501
CY2023 dei Auditor Location
AuditorLocation
San Diego, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72625 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
293878 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
52148 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
80813 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
30398 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
243273 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1570 usd
CY2023Q4 QURT Notes Receivable Related Party Net Of Current Portion And Discount
NotesReceivableRelatedPartyNetOfCurrentPortionAndDiscount
13630 usd
CY2023Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
28673 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
24069 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
35896 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
438471 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
35896 usd
CY2023Q4 us-gaap Assets
Assets
683314 usd
CY2022Q4 us-gaap Assets
Assets
753752 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
105244 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
83299 usd
CY2023 us-gaap Gross Profit
GrossProfit
183363 usd
CY2022 us-gaap Gross Profit
GrossProfit
396650 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31518 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47705 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
49940 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
43735 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
114671 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
167766 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
196129 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
259206 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-12766 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
137444 usd
CY2023 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
303 usd
CY2022 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
285 usd
CY2023 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
36 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
46578 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
25769 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-78158 usd
CY2023 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-3529 usd
CY2022 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-41118 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56319 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18453 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11827 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3875 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
44492 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14578 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15674483 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15674483 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334523 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14578 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
349101 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
349101 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
393593 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
393593 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
44492 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14578 usd
CY2023 us-gaap Depreciation
Depreciation
800 usd
CY2022 us-gaap Depreciation
Depreciation
800 usd
CY2023 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
36 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-3529 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-41118 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
25769 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-78158 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11827 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3875 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-54369 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3406 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-155670 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
99281 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
28673 usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
51578 usd
CY2023 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50% likely
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21945 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3778 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-187000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
187000 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
50125 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-33406 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49773 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
200026 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
201894 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
259133 usd
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
57920 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
425481 usd
CY2023 QURT Payments For Proceeds From Issuance Of Notes Payable Related Party
PaymentsForProceedsFromIssuanceOfNotesPayableRelatedParty
-415000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-271026 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-166348 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-221253 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33678 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
293878 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
260200 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
72625 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
293878 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80B_eus-gaap--NatureOfOperations_zLCCmTFbDLhi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_822_z71ySKxc6C16">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quarta-Rad, Inc. (the “Company”) was incorporated under the laws of the state of Delaware on November 29, 2011, under the name Quatra-Rad, Inc. and amended its Certificate of Incorporation on February 29, 2012 to change its name to Quarta-Rad, Inc. On July 2, 2012, the Company amended and restated its Certificate of Incorporation to increase its authorized shares of common stock to <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20120702__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedMember__srt--RangeAxis__srt--MaximumMember_z1FpKmLqENH9" title="Common stock, shares authorized">50,000,000</span>, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20120702__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedMember__srt--RangeAxis__srt--MaximumMember_zNnWkwUg3FYa" title="Common stock, par value">0.0001</span> par value from <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20120702__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedMember_ztPMKQMJxzmg" title="Common stock, shares authorized">1,500</span>, <span id="xdx_904_eus-gaap--CommonStockNoParValue_iI_do_c20120702__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedMember_zVQwKvGKUQo6" title="Common stock, par value">no</span> par value. The Company distributes detection devices, including but not limited to Geiger counters, to homeowners and interested customers in North America, Europe, and Asia. The Company targets homebuilders and home renovation contractors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During April 2020, the Company acquired Quarta-Rad USA, Inc., a Delaware corporation, as a wholly owned subsidiary. There was no consideration paid for the shares. The purpose of the acquisition is to separate the sales of certain products in separate entities. There was no activity, assets or liabilities in the subsidiary through December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During December 2020, the Company acquired Sellavir, Inc., a Delaware. Corporation, as a wholly owned subsidiary, as discussed in Note 7. Sellavir is a video analytics company whose platform empowers organizations to decode videos to develop creative marketing strategies and analysis through advanced and proprietary technologies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zQzCxybirMVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zK4kyxGk7VDd">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates made by management include, among others, provisions for the valuation of related party notes receivable. The Company bases its estimates on historical experience, knowledge of current conditions and belief of what could occur in the future considering available information. The Company reviews its estimates on an on-going basis. The actual results experienced by the Company may differ materially and adversely from its estimates. To the extent there are material differences between the estimates and actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Advertising Expense
AdvertisingExpense
49940 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
43735 usd
CY2023Q4 QURT Reduction Of Revenues
ReductionOfRevenues
21488 usd
CY2023 us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.10 pure
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcJrofQuHnue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zAZEiavzdCI2">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit is extended to online platforms and suppliers based on an evaluation of their financial condition, and collateral is generally not required. The Company performs ongoing credit evaluations of its customers and provides an allowance for doubtful accounts as appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two selling platforms/distributors accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoSellersMember_zh2d7al3uEEd" title="Concentration risk, percentage">88</span>% of accounts receivable at December 31, 2023 and two selling platforms/distributors accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoSellersMember_zsrSwoTAYYab" title="Concentration risk, percentage">96</span>% of accounts receivable at December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quarta Rad purchased <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdPartyMember_zx2kD184LKZh" title="Concentration risk, percentage">100</span>% of its inventory through a third party in 2023. Quarta Rad purchased <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoRelatedPartyVendorsMember_zc90N4yK612a" title="Concentration risk, percentage">100</span>% of its inventory through two related party vendors during 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
52148 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
52148 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
173882 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
173882 usd
CY2023Q4 QURT Financing Receivables Minimum Payments Year One
FinancingReceivablesMinimumPaymentsYearOne
80813 usd
CY2023Q4 QURT Financing Receivables Minimum Payments Year Two
FinancingReceivablesMinimumPaymentsYearTwo
107760 usd
CY2023Q4 QURT Financing Receivables Minimum Payments Year Three
FinancingReceivablesMinimumPaymentsYearThree
107760 usd
CY2023Q4 QURT Financing Receivables Minimum Payments Year Four
FinancingReceivablesMinimumPaymentsYearFour
107760 usd
CY2023Q4 QURT Financing Receivables Minimum Payments Year Five
FinancingReceivablesMinimumPaymentsYearFive
31975 usd
CY2023Q4 QURT Financing Receivables Minimum Payments
FinancingReceivablesMinimumPayments
436068 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4005 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4005 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2435 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1635 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1570 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2370 usd
CY2023 us-gaap Depreciation
Depreciation
800 usd
CY2022 us-gaap Depreciation
Depreciation
800 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
11827 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3875 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11827 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3875 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11827 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3875 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
69000 usd
CY2023 QURT Operating Loss Carry Forwards Expiration Date Description
OperatingLossCarryForwardsExpirationDateDescription
through 2039
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14777 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3651 usd
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1260 usd
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1260 usd
CY2023Q4 QURT Deferred Tax Assets Accrued Interest Related Party
DeferredTaxAssetsAccruedInterestRelatedParty
-9781 usd
CY2023Q4 QURT Deferred Tax Assets Accrued Expenses Related Party
DeferredTaxAssetsAccruedExpensesRelatedParty
-7560 usd
CY2023Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
25373 usd
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
30785 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
24069 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35696 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
24069 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
35696 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they chose to do so, elect all of the directors of the Company.
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 usd
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
468679 usd
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
22473 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-12766 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
44492 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1100431 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
137444 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14578 usd
CY2023Q4 us-gaap Assets
Assets
683314 usd
CY2022Q4 us-gaap Assets
Assets
753752 usd
CY2019Q4 QURT Estimated Liabilities On Value Added Tax
EstimatedLiabilitiesOnValueAddedTax
100000 usd
CY2023 us-gaap Payments For Other Taxes
PaymentsForOtherTaxes
81825 usd
CY2023 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
18175 usd

Files In Submission

Name View Source Status
0001493152-24-012312-index-headers.html Edgar Link pending
0001493152-24-012312-index.html Edgar Link pending
0001493152-24-012312.txt Edgar Link pending
0001493152-24-012312-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qurt-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qurt-20231231_cal.xml Edgar Link unprocessable
qurt-20231231_def.xml Edgar Link unprocessable
qurt-20231231_lab.xml Edgar Link unprocessable
qurt-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending